GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CDT Equity CDT · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.84

-35.87%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$2.72bn

FY2021FY2025

Net income

−$39.2m

FY2021FY2025

Free cash flow

−$18.0m

FY2021FY2025

Shareholders' equity

$1.26bn

FY2021FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Revenue$2.72bn$922.2m———
Research and development$5.1m$3.4m$90,000$111,000$283,000
Operating income−$38.9m−$16.3m−$5.3m−$3.2m−$3.2m
Net income−$39.2m−$17.8m−$535,000−$4.9m−$3.7m
Diluted earnings per share-42.57-2,580.00-93.86-3,759.23-12,190.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Total assets$3.54bn$4.2m$7.2m$5,000$213,125
Cash and short-term investments$389.9m$554,000$4.2m$345,777$48,555
Total liabilities$2.28bn$11.0m$7.7m$10.1m$192,506
Debt$1.29bn$7.5m$985,000$2.0m$177,057
Shareholders' equity$1.26bn−$6.8m−$457,000−$10.1m$20,619
Shares outstanding1m0m0m0m0m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021
Cash from operations−$15.6m−$9.7m−$7.7m−$2.3m−$2.2m
Capital spending−$2.4m−$51,000——−$5
Free cash flow−$18.0m−$9.7m−$7.7m−$2.3m−$2.2m
Dividends paid−$8.0m−$8.2m———

Growth per year

Compound annual rate

3 years5 years10 years
Operating income131.0%——
Net income100.2%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022
Price to earnings-0.0-10.6-0.4

Share price return

Finished calendar years

2025202420232022
Return-100%-98%-35%3%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 25-to-1 reverse split · 29 Sept 2026
  • 10-to-1 reverse split · 20 Jul 2026
  • 25-to-1 reverse split · 27 Mar 2026
  • 8-to-1 reverse split · 13 Oct 2025
  • 15-to-1 reverse split · 20 May 2025
  • 100-to-1 reverse split · 27 Jan 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.